Evidence map›Paper›PMID 42635222›Full record

ArticleBioinformatics (Oxford, England)2026

Multimodal contrastive learning for integrating molecular representations and cellular phenotypes in drug-target interaction prediction.

Ying-Ju Lai, Tianyuzhou Liang, Po-Yuan Chen, Yu-Che Tsai, George C Tseng, Yufei Huang, Yu-Chiao Chiu

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying-Ju LaiUPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, United States.
Tianyuzhou LiangUPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, United States.
Po-Yuan ChenInstitute of Biomedical Sciences, Academia Sinica, Taipei 115201, Taiwan.
Yu-Che TsaiDepartment of Computer Science and Information Engineering, National Taiwan University, Taipei 106319, Taiwan.
George C TsengDepartment of Biostatistics and Health Data Science, University of Pittsburgh, Pittsburgh, PA 15261, United States.ORCID 0000-0002-5447-1014
Yufei HuangUPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, United States.
Yu-Chiao ChiuUPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, United States.ORCID 0000-0003-1647-8634

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Dan Paul Zandberg · 1988 to 2026
$158.0M
Single-cell congruence evaluation and selection of cancer models towards precision medicineR01CA285337 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Adrian V Lee, George C. Tseng · 2025 to 2026
$1.2M
Novel computational approaches for pharmacogenomics of complex diseasesR35GM154967 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Yu-Chiao Chiu · 2024 to 2026
$1.2M
Enhancing AI-readiness of multi-omics data for cancer pharmacogenomicsR00CA248944 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHIU, YU-CHIAO · 2022 to 2024
$1.1M
Open science platform for cancer dependency prediction and analysis using deep learning and large language modelsR03CA305794 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Yu-Chiao Chiu · 2025 to 2026
$474k
NCI NIH HHS P30 CA047904NCI NIH HHS R00 CA248944NCI NIH HHS R01 CA285337NCI NIH HHS R03 CA305794NIGMS NIH HHS R35 GM154967NIH HHS R00CA248944NIH HHS R01CA285337NIH HHS R03CA305794NIH HHS R35GM154967UPMC Hillman Cancer Center P30CA047904
6 · The paper itself

Abstract

motivationAccurate prediction of drug-target interactions (DTIs) is fundamental to drug discovery and mechanistic understanding. While deep learning has advanced computational DTI prediction, most existing methods rely primarily on molecular structural representations, including drug structures and protein sequences, while overlooking cellular phenotypes that reflect downstream biological effects. Cell Painting enables high-content morphological profiling that captures systems-level responses to chemical and genetic perturbations but remains underutilized in DTI modeling. Integrating molecular information with cellular phenotypes offers an opportunity to improve both predictive performance and biological interpretability.

resultsWe propose a two-stage contrastive learning framework integrating drug structures, protein sequences, and Cell Painting morphological profiles into a unified embedding space. Stage 1 learns modality-specific representations independently from structure-based and image-based data; Stage 2 aligns these via multi-positive contrastive learning to bridge molecular structural information with cellular phenotypes. Cross-modal retrieval achieves median Recall@10 values of 0.77 (random split) and 0.33 (scaffold split), outperforming bilinear and random baselines. In external DTI prediction on the BIOSNAP dataset, our model achieves an AUC of 0.92 with image-based representations and 0.90 under structure-only settings, surpassing existing methods. Model interpretation via integrated gradients reveals pathway-specific morphological signatures associated with drug targets, providing biologically interpretable insights into drug mechanisms. AVAILABILITY: https://github.com/YJRubyLai/Unified-DTI.

Indexed as

Computational BiologyDeep LearningDrug DiscoveryHumansPhenotypeProteinsProteins

Identifiers

PMID42635222
PMCPMC13501321

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.